Newsfeeds - Spark Newswire

6 minute read

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs

Today, 7:51 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14)

ABCL

5 minute read

The Daily Biotech Pulse: Priority Review For Amgen’s Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test

By Shanthi Rexaline

Today, 7:51 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7)

ABCL

5 minute read

Uncategorized

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal

By Shanthi Rexaline

Today, 7:51 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24)

ADVM

2 minute read

Uncategorized

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 7:51 AM

On Wednesday morning, 19 companies hit new 52-week lows.

ADVM

8 minute read

Uncategorized

Benzinga’s Top Ratings Upgrades, Downgrades For May 3, 2021

By Benzinga Insights

Today, 7:51 AM

AACQ

8 minute read

Uncategorized

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge

By Shanthi Rexaline

Today, 7:51 AM

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions.

ABUS

6 minute read

Uncategorized

65 Biggest Movers From Yesterday

By Lisa Levin

Today, 7:51 AM

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) jumped 33.1% to settle at $3.34 on Thursday as the company said it has been named as sponsor related to 4 SPACs.

ADS

1 minute read

Uncategorized

Why Adverum Biotechnologies Stock Is Plummeting Today

By Tyree Gorges

Today, 7:51 AM

Adverum Biotechnologies (NASDAQ: ADVM) shares are trading lower after the company announced a Suspected Unexpected Serious Adverse Reaction of hypotony in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema.

ADVM

2 minute read

Uncategorized

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 7:51 AM

ADVM

3 minute read

Uncategorized

Mid-Day Market Update: Nasdaq Turns Lower; Galera Therapeutics Shares Surge

By Lisa Levin

Today, 7:51 AM

Midway through trading Thursday, the Dow traded up 0.14% to 33,868.84 while the NASDAQ fell 0.33% to 14,004.20. The S&P also rose, gaining 0.15% to 4,189.46.

ADVM